Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT03650803
Eligibility Criteria:
Inclusion Criteria:
* Biopsy proven cases of breast cancer
Exclusion Criteria:
* Patients with onlybenign lesion
* Patients with onlyductal carcinomain situ (DCIS)
* Patients with recurrent/ residual breast cancer in same breast
* Pregnant women
* Lactating Women6.Patients with ferromagnetic or otherwise non-MRI compatible aneurysm clips.
* The presence of an implanted medical device that is not MRI-compatible, including, but not limited to: pacemaker, defibrillator
* Patients with contraindications for MRIdue to embedded foreign metallic objects. Bullets, shrapnel, metalwork fragments, or other metallic material adds unnecessary risk to the patient.
* Known history of severe claustrophobia
* Patients under the age of 18
* For patients with known history of allergic reaction to MR contrast material or abnormal kidney function (GFR \< 40 mL/ min), a contrast enhanced exam will not be performed; however, a non-contrast exam may be performed in these patients.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03650803
Study Brief:
Protocol Section:
NCT03650803